High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial (Q45048847)
Jump to navigation
Jump to search
scientific article published on 7 September 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial |
scientific article published on 7 September 2004 |
Statements
1 reference
High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial (English)
1 reference
Joseph L Witztum
1 reference
Sotirios Tsimikas
1 reference
Michael Szarek
1 reference
Elizabeth R Miller
1 reference
William J Sasiela
1 reference
Anders G Olsson
1 reference
Gregory G Schwartz
1 reference
Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators
1 reference
7 September 2004
1 reference
1 reference
110
1 reference
11
1 reference
1406-1412
1 reference
Identifiers
1 reference
1 reference